September 3, 2019 — Corindus Vascular Robotics Inc. announced that EClinicalMedicine, a clinical journal published...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
Technology | Vascular Access | September 03, 2019
September 3, 2019 — New Zealand-based Adept Medical announced the launch of the Antegrade IR Platform. Clinically...
The most popular cardiac technology news in August 2019 was the FDA clearance for a new indication for both the Edwards Sapien 3 and Medtronic CoreValve transcatheter aortic valve replacement (TAVR) devices for low-risk patients. This puts the technology on equal footing with the previous standard-of-care of open heart surgery, representing a paradigm shift in cardiology.
Feature | September 03, 2019 | Dave Fornell, Editor
September 3, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (...
News | Hemostasis Management | August 29, 2019
August 29, 2019 – Merit Medical Systems Inc. announced the U.S. commercial launch of the PreludeSync Evo...
Feature | Peripheral Artery Disease (PAD) | August 28, 2019 | Jeff Zagoudis, Associate Editor
August 28, 2019 — The U.S. Food and Drug Administration (FDA) released an updated MedWatch Alert this month on the...
News | Left Atrial Appendage (LAA) Occluders | August 28, 2019
August 28, 2019 — AtriCure Inc. announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance...
News | Cath Lab | August 27, 2019
August 27, 2019 — Imagine there were a drug that you could take soon after a...
News | Peripheral Artery Disease (PAD) | August 27, 2019
August 27, 2019 — Concept Medical was recently granted Breakthrough Therapy designation by the U.S. Food and Drug...
An illustration of the BASILICA procedure showing the leaflet of the original bioprosthetic valve sliced open to allow coronary blood flow after implantation of a TAVR valve. The new TAVR valve can push the leaflets of the bioprosthetic valve upwards, blocking the coronary arteries. During the BASILICA procedure, a catheter directs an electrified guidewire through the base of the left aortic cusp into a snare in the left ventricular outflow tract (LVOT). After snare retrieval, the mid-shaft of the guidewire is electrified to lacerate the leaflet, and the the leaflet splays after TAVR permitting coronary flow.
Feature | Heart Valve Technology | August 27, 2019
A novel technique has proven successful in preventing coronary artery obstruction during transcatheter aortic valve...
Image courtesy of the American Heart Association
News | Population Health | August 26, 2019
August 26, 2019 — Areas with a higher number of fast food restaurants have more...
Technology | Catheters | August 23, 2019
August 23, 2019 — Cook Medical recently released the second generation of the 2.6 Fr CXI...
News | Heart Valve Technology | August 22, 2019
August 22, 2019 — Edwards Lifesciences is recalling the Sapien 3 Ultra...
News | Stents | August 21, 2019
August 21, 2019 — Increasing incidence of cardiovascular diseases worldwide is creating growth opportunities for the...
